Take the NHS Genomic Medicine Service Survey
Date: 29 September 2026
A survey has been generated for NHS Genomic Medicine Service committee members to support evidence gathering to understand site level governance reviews in line with local GMO risk assessment processes to ascertain factors that may contribute to delays, explore access to expertise, class and containment decisions and view on a standardised approach.
Results will feed into a Pan-UK Advanced Therapy Medicinal Products (ATMP) Local Operations Group (initiated by the MHRA/HRA) to build a picture of current practices and inform discussions on streamlining future GMO risk assessment processes.
Take the survey via this link